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Abstract
Objective: The time constant of the cerebral arterial bed (τ), which is an index of brain
haemodynamics, can be estimated in patients using continuous monitoring of arterial blood
pressure (ABP), transcranial Doppler cerebral blood flow velocity (CBFV) and intracranial
pressure (ICP) if these measures are available. But, in some clinical scenarios invasive measurement
of ABP is not feasible. Therefore, in this study we aimed to investigate whether invasive ABP can be
replaced with non-invasive ABP, monitored using the Finapres photoplethysmograph (fABP).
Approach: Forty-six recordings of ICP, ABP, fABP, and CBFV in the right and left middle cerebral
arteries were performed daily for approximately 30 min in 10 head injury patients. Two modelling
approaches (constant flow forward [CFF, pulsatile blood inflow and steady blood outflow] and
pulsatile flow forward [PFF, where both blood inflow and outflow are pulsatile]) were applied to
estimate τ using either invasive ABP (τCFF, τPFF) or non-invasive ABP (fτCFF, fτPFF).Main results:
Bland–Altman analysis showed quite poor agreement between the fτ and τmethods of estimation.
The fτmethod produced significantly higher values than the τmethod when calculated using both
the CFF and PFF models (p < .001 for both). The correlation between fτCFF and τCFF was
moderately high (rs = 0.63; p < .001), whereas that between fτPFF and τPFF was weaker (rs = 0.40;
p= .009). Significance: Our results suggest that using non-invasive ABP for estimation of τ is
inaccurate in head injury patients.
1. Introduction
The time constant of the cerebral arterial bed (τ) is an ultrasound–based index which estimates the time
needed to fill the cerebral arterial bed with blood after heart constriction. The τ index reflects the interplay
between cerebrovascular resistance (CVR) and compliance of the cerebral arterial bed (Ca), and is
independent of the unknown cross-sectional area of the insonated cerebral artery (Kasprowicz et al 2012a,
2012c). An estimate of the amplitude of pulsatile changes in cerebral arterial blood volume (Amp (∆CaBV))
is needed to calculate Ca. Currently, two mathematical models for continuous∆CaBV assessment have been
proposed (Kim et al 2009, Uryga et al 2019b). The first presumes that cerebral blood outflow has lower
pulsatility than cerebral blood inflow, and therefore that cerebral blood outflow may be approximated by
average cerebral arterial inflow. This approach is referred to as the continuous flow forward (CFF) model.
The second model, known as the pulsatile flow forward (PFF) model, recognizes that cerebral blood outflow
is dependent on the impedance of the afferent part of the vascular system. The PFF model therefore expresses
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cerebral blood outflow as the ratio of arterial blood pressure (ABP) to CVR. Thus, two alternative estimation
methods of ￿ (a product of Ca and CVR) are possible (τCFF, τPFF).
The τ index (estimated using either the CFF model or PFF model) has been widely applied in studying
cerebral haemodynamics in the presence of head injuries (Calviello et al 2019, Puppo et al 2019),
hydrocephalus (Capel et al 2014), severe carotid occlusive disease (Kasprowicz et al 2012b), and
subarachnoid haemorrhages (Kasprowicz et al 2012a), as well as in both healthy volunteers (Kasprowicz et al
2012c, Uryga et al 2019a) and experimental studies (Czosnyka et al 2012). It has also been found that τ is
correlated with severity of artery derangement in carotid stenosis (Kasprowicz et al 2012b) and that it
becomes shorter during vasospasm in patients after a subarachnoid haemorrhage (Kasprowicz et al 2012a).
Ragland and Lee (2016) note that, in situations such as acute brain injury, stroke or intracerebral
haemorrhage, where expansion in intracranial volume is observed, τ can be estimated in patients by
continuously monitoring ABP, cerebral blood flow velocity (CBFV) and intracranial pressure (ICP). In
clinical practice, ABP is assessed using a radial or brachial artery catheter and ICP is tracked via a
parenchymal or ventricular intracranial probe, thus both signals are measured in an invasive manner.
However, in some clinical scenarios where characterization of cerebral haemodynamics can be beneficial,
invasive ABP measurements are not required. Such scenarios include infusion testing (Czosnyka et al 2016)
and overnight monitoring of ICP (Liew et al 2019) in patients suffering from hydrocephalus. Moreover,
difficulties in placing arterial lines and the possibility of infection during invasive monitoring make
non-invasive ABP monitoring a promising alternative for critical care and anaesthesia scenarios
(Chatterjee et al 2010).
Non-invasive measurement of ABP using the Finapres device has been compared with invasive ABP
when making resting measurements and has indicated that the accuracy and precision of the device is
adequate for tracking changes in blood pressure (Stokes et al 1991, Silke et al 1994, Imholz et al 1998). Also, a
study of the possibility of assessing dynamic cerebral autoregulation using slow waves of ABP derived using
the Finapres device has shown good agreement between non-invasive and invasive autoregulation indices
(Lavinio et al 2007, Petersen et al 2014). Additionally, a cerebrovascular reactivity index has been shown to be
sensitive enough to distinguish between passive and active reactivity (Kasprowicz et al 2010).
Despite the above work, there have been no tests of whether invasive ABP measurement can be replaced
by non-invasive ABP measurement in assessing pulsatile changes in cerebral blood volume. The present
study therefore aimed to investigate whether non-invasive ABP, measured by the Finapres
photoplethysmograph, can achieve results comparable to those of invasive ABP in the estimation of τ.
2. Material andmethods
2.1. Subjects
Data for 10 patients hospitalized due to severe head injury in 1992 and managed in the Neurosurgical Critical
Care Annexe of Addenbrooke’s Hospital, Cambridge, UK were retrospectively analysed. The same set of data
was previously used for a comparison of autoregulation assessment and cerebrovascular pressure reactivity in
the low frequency range between invasive and non–invasive ABP (Lavinio et al 2007, Kasprowicz et al 2010).
All subjects were adults (age⩾ 18 years). The patients were treated following the cerebral perfusion
pressure/intracranial pressure (CPP/ICP) methodology later formalized as a set protocol (Menon 1999).
Data were anonymized and computer–recorded during standard daily assessment of autoregulation after
head injury. Blood pressure (direct continuous), ICP (direct, continuous) and transcranial Doppler (daily
intermittent monitoring) were routine clinical methods for monitoring of traumatic brain injury (TBI)
patients in the Annexe. The Neurosurgical Intensive Care User’s Committee accepted the use of intermittent
non-invasive Finapres blood pressure monitoring without the necessity of obtaining individual consent from
patients’ next of kin.
2.2. Data acquisition
Forty-six ABP, ICP and CBFV recordings in both brain hemispheres were analysed. ABP was monitored
invasively using an arterial line positioned in the radial artery and a pressure transducer (Baxter Healthcare
Cardiovascular Group). The average number of recordings per patient (calculated as a weighted average) was
5. Non-invasive ABP (fABP) was measured using the Finapres device (Finapres 2300, Ohmeda, Englewood,
CO), which is a servo-controlled photoplethysmograph. The measurement principle is based on
‘volume–clamping’ a finger with a cuff, adjusting its pressure to maintain a signal of infrared amplitude at a
constant level (Stokes et al 1991). Patients’ hands were placed at heart level during monitoring. ICP was
monitored invasively using a Codman parenchymal probe (Johnson & Johnson Medical, Raynham,
Massachusetts). CBFV measurements were obtained continuously in the left (CBFVL) and right (CBFVR)
middle cerebral arteries (MCA) by transcranial Doppler ultrasonography (TCD) (DWL-MultiDop, DWL,
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Figure 1. (A) Time trends of pulsatile changes in intracranial pressure (ICP), invasive arterial blood pressure (ABP), non-invasive
arterial blood pressure (fABP), and cerebral blood flow velocity in the left and right middle cerebral arteries (CBFVL and CBFVR).
(B) Normalised pulsatile changes in cerebral arterial blood volume, calculated using the continuous flow forward model
(n∆CaBVCFF) and the pulsatile flow forward model using invasive ABP (n∆CaBVPFF) and non-invasive ABP (fn∆CaBVPFF) in a
severe head injury patient.
Compumedics Germany GmbH, Singen, Germany) using 2 MHz probes. CPP was calculated as the
difference between ABP and ICP. Sequential measurements for the same patients were taken with a
minimum 24-hour gap, thus recordings could be analysed as independent monitoring sessions. Data were
recorded with a sampling frequency of 50 Hz using the Intensive Care Monitor (ICM+) system (Cambridge
Enterprise Ltd, Cambridge, UK). Examples of time trends of the monitored physiological signals are
presented in figure 1(A).
2.3. Signal analysis
The signals recorded were analysed using algorithms embedded in the ICM+ system and with a custom
written program in MATLAB® (MathWorks®, Natick, USA). Artefacts, including self–calibration intervals in
fABP signals, were identified by visual inspection, marked manually and ultimately removed. Further
analysis was performed on the representative parts of signals. ABP, fABP, ICP, CBFVL, and CBFVR samples
were averaged over a 10 s window to calculate their mean values.
Linear systems theory was applied to determine whether pulse changes in ABP signals could be detected
by Finapres monitoring. We calculated spectral mean coherence and mean values of the transfer gain
function between ABP and fABP in the high-frequency range, corresponding to pulse pressure changes
(40–140 beats min−1; 0.67–2.33 [Hz]). The coherence function assesses how much invasive and non-invasive
pressure pulse changes resemble each other (1= perfect resemblance, 0= no resemblance). A transfer
function gain between ABP and fABP close to 1 reflects similarity in their amplitudes.
The cerebrovascular indices were estimated using a simplified cerebral circulation model (Czosnyka et al
1997) and averaged in a 10-second window. Parameters which, by definition, depended on unknown
cross-sectional areas of arteries (Sa [cm2]) were normalized and given an ‘n’ prefix (nCVR, nCa, n∆CaBV).
Formulas used to calculate the cerebrovascular parameters are discussed in detail elsewhere (Varsos et al 2014,
Uryga et al 2019b). Here, we restrict ourselves to a brief description of previously mentioned parameters.
CVR is the resistance of small cerebral arteries and arterioles, and is defined as the ratio of mean cerebral
perfusion pressure (CPP= ABP− ICP) to mean cerebral blood flow (CBF), approximated here by mean
CBFV (Czosnyka et al 1994):
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wherem is the number of samples, t is the time interval between two samples, CPP(i) is a sample’s cerebral
perfusion pressure, CBFV(i) is a sample’s CBFV, and mean(CBFV) is the moving-average of CBFV calculated
from a window including several previous cardiac cycles (Czosnyka et al 2012). Examples of time trends for
n∆CaBVCFF and n∆CaBVPFF calculated using fABP and ABP in the left hemisphere are presented in figure
1(B).
There are two possible equations for calculating Amp(n∆CaBV). In the CFF model the pulsatile
amplitude of n∆CaBV is determined using a Fourier transform as the amplitude of the fundamental
components of n∆CaBVCFF: (Amp(n∆CaBVCFF)), whereas in the PFF model, in order to account for time
delay between CBFV recorded from the cerebral arteries and ABP from a finger, the pulsatile amplitude of





Amp(CBFV) and Amp(CPP) are determined using a Fourier transform as the amplitude of the fundamental
components of CBFV and CPP respectively, and HR is heart rate in Hz, calculated as the frequency of the
fundamental component of the ABP signal using a Fourier transform.
To test the influence of the time window length used to average CBFV on the pulsatile amplitude of
n∆CaBVCFF the following time periods were used: 3 s, 6 s, 9 s, and 12 s. The optimal time window was
chosen based on the highest correlation coefficient between τCFF values calculated using invasive and
non-invasive ABP (see table 3).
The τ index is the time needed to stabilize cerebral blood volume after a change in ABP during a cardiac
cycle (Kasprowicz et al 2012a) and is defined as the product of Ca and CVR:
τ = nCa · nCVR[s]. (6)
In a scenario where ABP can be monitored invasively and non-invasively, using both the CFF and PFF
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Table 1.Median values and interquartile ranges (Q1–Q3) of physiological parameters for 46 recordings performed in severe head injury
patients.
Parameter Median (Q1–Q3)
ABP [mm Hg] 91.76 (87.09–100.85)
fABP [mm Hg] 86.33 (74.07–92.00)
Amp(ABP) [mm Hg] 17.63 (16.06–19.47)









HR [beats min−1] 81.56 (68.10–95.03)
fHR [beats min−1] 77.84 (68.60–92.31)
ICP [mm Hg] 15.16 (11.50–18.48)
CPP [mm Hg] 77.38 (74.73–82.10)
fCPP [mm Hg] 66.79 (61.57–77.20)
ABP—invasive arterial blood pressure; fABP—non-invasive arterial blood pressure; Amp(ABP)—amplitude of ABP pulse changes;
Amp(fABP)—amplitude of fABP pulse changes; CBFVL—cerebral blood flow velocity in the left middle cerebral artery;
CBFVR–cerebral blood flow velocity in the right middle cerebral artery; Amp(CBFVL)-amplitude of CBFVL pulse changes;
Amp(CBFVR)—amplitude of CBFVR pulse changes; HR—heart rate, calculated from ABP signals; fHR—heart rate calculated from
fABP signals; ICP—intracranial pressure; CPP—cerebral perfusion pressure, calculated using invasive ABP: CPP= ABP–ICP;
fCPP—cerebral perfusion pressure, calculated using non-invasive ABP: CPP= fABP–ICP.
where fHR is heart rate in Hz, calculated as the frequency of the fundamental component of the fABP signal
using a Fourier transform, fCPP is cerebral perfusion pressure (defined as fCPP= fABP− ICP), and
Amp(fCPP) is the amplitude of the fundamental component of the fCPP, determined using a Fourier
transform.
2.4. Statistical methods
Normality of data distributions was tested using Shapiro–Wilk tests. The hypothesis of normality was
rejected for most of the analysed variables and therefore non-parametric methods were used. The criterion
for significance was set at α= .05. Descriptive statistics are presented as medians (lower quartile–upper
quartile). Relationships between pairs of physiological and haemodynamic parameters were assessed using
(non-parametric) Spearman’s rho correlation coefficients (rs). Bland–Altman assessments of agreement were
used to compare the two methods of calculating cerebral hemodynamic indices (using fABP and ABP),
non-invasive vs. invasive measurement of arterial blood pressure, and amplitude of arterial blood pressure
(fABP vs. ABP, and Amp(fABP) vs. Amp(ABP)). To assess bias and the limits of agreement between methods,
approach proposed by Bland and Altman were used whereby a logarithmic transformation is applied for
non–normally distributed differences between methods (Bland and Altman 1986, 1999). Mann–Whitney U
tests were used to test differences between two physiological variables or cerebral hemodynamic indices.
Effect sizes for tests are reported in terms of eta squared (η2) values (Fritz et al 2012).
3. Results
3.1. Physiological signals
The median values of physiological parameters are presented in table 1. No significant differences were found
between CBFVL and CBFVR: z =−0.13, p= .897, or between their amplitudes: Amp(CBFVL) vs.
Amp(CBFVR): z = 0.33, p= .740. Thus, cerebral haemodynamic parameters were averaged within the left
and right hemispheres for further analyses.
3.2. Comparison of the fABP and ABP
Mean ABP and its pulse amplitude measured with Finapres were lower than values obtained by direct
pressure measurement (see table 1): z =−3.50, p < .001, and z =−7.75, p < .001, respectively. The effect size
for the difference between the non-invasive and invasive methods of measuring ABP was small (η2 = 0.14),
whereas for AmpABP the effect size was moderate (η2 = 0.67). ABP was strongly correlated with fABP (see
figure 2(A)) whereas the correlation between Amp(ABP) and Amp(fABP) was moderate (see figure 2(C)).
Statistics resulting from Bland–Altman analyses of agreement between fABP vs. ABP and between
Amp(fABP) vs. Amp(ABP) are shown in table 2. The results indicated that, on average, ABP derived from the
Finapres was 10.36 mm Hg less than that measured with an invasive arterial line. The difference between the
two methods tended to be positive, thus for greater average values of blood pressure the non-invasive method
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Figure 2. Correlations and Bland–Altman plots for arterial blood pressure and amplitude of arterial blood pressure measured
non-invasively and invasively: fABP vs. ABP (A) and (B), and Amp(fABP) vs. Amp(ABP) (C) and (D). Regression lines (solid
lines) and 95% prediction intervals (dashed lines) are shown in (A) and (C); rs—non-parametric Spearman’s rho correlation
coefficients. The solid lines in (B) and (D) show bias (upper and lower limits of agreement), whereas dashed lines show 95%
confidence intervals for these limits; CI—confidence interval, SD—standard deviation.
produced slightly higher measurements than the invasive method (see figure 2(B)). Amp(fABP) was on
average 6.49 mm Hg lower than Amp(ABP). The difference between Amp(fABP) and Amp(ABP) fluctuated
around the mean bias but the range between the limits of agreement was wide (see figure 2(D)). Median
coherence and the transfer function gain between fABP and ABP calculated within a range of
40–140 beats min−1 were 0.90 (0.85–0.96) [a.u.] and 0.78 (0.67–.90) [a.u.] respectively, which implies good
linear coupling between fABP and ABP and moderate amplitude attenuation in the frequency range
corresponding to pulse pressure changes (see figure 3(A)). The median phase shift (± the interquartile
range) between fABP and ABP calculated in the high-frequency range, corresponding to pulse pressure
changes (40–140 beats min−1; 0.67–2.33 [Hz]), was−1.90◦ (±10.63◦), and the mean (±SD) was 0.80◦
(±8.93◦). The observed phase shift was negligible in comparison with no phase shift (0◦), which indicates
consistency in phases for fABP and ABP. The time delay between pulse waves of these two signals was
approximately 4 ms on average (see figure 3(B)).
3.3. nCVR calculated using fABP and ABP
The nCVR estimated using non-invasive ABP (fnCVR) was significantly lower than that calculated with
invasive ABP (nCVR): 1.41 (1.18–1.76) mm Hg cm−1 s−1 vs. 1.79 (1.31–2.06) mm Hg cm−1 s−1; z =−2.53,
p= .011. A small effect size was found for this difference (η2 = 0.07). The correlation between fnCVR and
nCVR was very strong (see table 2). The mean bias was−0.27 mm Hg cm−1 s−1) and the range between the
limits of agreement was moderate (see table 2). A negative tendency was found for the difference between the
fnCVR and CVR methods, with increasing averages for these two methods.
3.4. Selection of the optimal moving–average window for n∆CaBVCFF calculation
The results of the method used to select the optimal moving–average window applied to calculate mean
CBFV and then used in estimation of the pulsatile amplitude of n∆CaBVCFF, are presented in table 3. Based
on the mean bias, upper and lower limits of agreement and the rs between fτCFF and τCFF, a 3 s window was
chosen. Given that the median invasive HR was 81.56 (68.10–95.03) [beats min−1], the 3 s window involved
approximately four previous cardiac cycles.
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Table 2.Mean values of bias, lower limits of agreement and upper limits of agreement with 95% confidence intervals for non-invasive
and invasive methods of arterial blood pressure monitoring and cerebral haemodynamics, according to Bland–Altman statistics, and
non-parametric Spearman’s rho correlation coefficients (rs).
Methods Bias Lower limit of agreement Upper limit of agreement rS










−6.49 (−7.23 to−5.75) −11.36 (−12.64
to−10.09)
−1.62 (−2.90 to−0.34) 0.48 p < .001
fnCVR vs. nCVR
[mm Hg/cm/s]




0.08 (0.03–0.13) −0.24 (−0.33 to−0.15) 0.41 (0.32–0.50) 0.91 p < .001
ln(fnCaCFF) vs.
ln(nCaCFF) [a.u.]
0.51 (0.44–0.58) 0.07 (−0.05 to 0.18) 0.95 (0.83–1.07) 0.81 p < .001
ln(fnCaPFF) vs.
ln(nCaPFF) [a.u.]
0.91 (0.62–1.20) −0.92 (−1.43 to−0.42) 2.75 (2.24–3.25) 0.45 p= .003
fτCFF vs. τCFF [ms] 55.72 (40.05–71.40) −46.55 (−73.70
to−19.39)
158.00 (130.84–185.15) 0.63 p < .001
ln(fτPFF) vs. ln(τPFF)
[a.u.]
0.85 (0.60–1.10) −0.72 (−1.16 to−0.29) 2.42 (1.99–2.86) 0.40 p= .009
CFF–continuous flow forward model; PFF—pulsatile flow forward model; fABP and ABP—non-invasive and invasive arterial blood
pressure; Amp(fABP) and Amp(ABP)—amplitude of fABP and ABP pulse changes; fnCVR and nCVR—normalised cerebrovascular
resistance, calculated using fABP and ABP; Amp(fn∆CaBVPFF) and Amp(n∆CaBVPFF)—amplitude of normalised pulse changes in
cerebral arterial blood volume, estimated using the PFF model and either fABP or ABP; ln(fnCaCFF) and ln(nCaCFF)—natural logarithm
of normalised compliance of the cerebral arterial bed, estimated using the CFF model and either fABP or ABP; ln(fnCaPFF) and
ln(nCaPFF)—natural logarithm of normalised compliance of the cerebral arterial bed, estimated using the PFF model and either fABP or
ABP; fτCFF and τCFF—time constant of the cerebral arterial bed, estimated using the CFF model and either fABP or ABP; ln(fτPFF) and
ln(τPFF)—natural logarithm of the time constant of the cerebral arterial bed, estimated using the PFF model and either fABP or ABP.
3.5. Amp(n∆CaBVPFF) calculated using fABP and ABP
No significant difference was found between Amp(n∆CaBVPFF) calculated using fABP: 0.40± 0.29 [cm] and
ABP 0.35± 0.34 [cm]; z = 1.08, p= .282. Amp(n∆CaBVPFF) calculated using fABP was very strongly
correlated with ABP and the mean bias between methods was negligible (see table 2). Since the ABP signal is
not used to calculate Amp(n∆CaBVCFF; see equation (3)), such a comparison was not performed for the CFF
model.
3.6. nCa calculated using fABP and ABP
3.6.1. The CFF model.
A significant difference was found between nCaCFF estimated using non-invasive ABP and nCaCFF estimated
using invasive ABP: (fnCaCFF: 0.14 (0.11–0.18) [cm/mm Hg] vs. nCaCFF: 0.08 (0.07–0.11) [cm/mm Hg];
z = 5.49, p < .001). This difference had a moderate effect size: η2 = 0.33, and fnCaCFF correlated strongly
with nCaCFF (see figure 4(A)). The range of agreement was moderately wide and fnCaCFF was on average 1.66
times greater than nCaCFF (see table 2 and figure 4(B)).
3.6.2. The PFF model.
For the PFF model, nCaPFF estimated using non-invasive ABP was significantly higher than its equivalent
calculated using invasive ABP: (fnCaPFF: 0.06 (0.04–0.09) [cm/mm Hg] vs. nCaPFF: 0.02 (0.01–0.04) [cm/mm
Hg]; z = 5.70, p < .001). A large effect size was observed for this difference: η2 = 0.36. The correlation
between fnCaPFF and nCaPFF was moderate (see figure 4(C)). The mean ratio of fnCaPFF to nCaPFF was 2.49, as
shown in table 2 and figure 4(D).
3.7. Comparison of fτ and τ
Median values of fτ and τ calculated using the CFF and PFF models are shown in table 4.
3.7.1. The CFF model.
Calculation of fτCFF using non-invasive ABP was significantly higher than τCFF estimated using invasive ABP
(see table 4), a large effect size being observed for this difference: η2 = 0.41. Also, fτCFF and τCFF were
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Figure 3. (A) Examples of mean coherence and mean transfer function gain calculated between invasive arterial blood pressure
(ABP, input) and non-invasive arterial blood pressure (fABP, output) in the high-frequency range (40–140 beats per minute;
0.67–2.33 Hz). (B) An example of the time delay between pulse waves of ABP and fABP: A—time lag between ABP and fABP
equals 10 ms; B—a single unit on the axis scale equals 200 ms.
Table 3. Bland–Altman statistics for the difference between the time constant of the cerebral arterial bed estimated using the continuous
flow forward model (CFF) and either non-invasive arterial blood pressure (fτCFF) or invasive blood pressure (τCFF). Results are
presented as means with 95% confidence intervals and expressed in ms; rs non-parametric Spearman’s rho correlation coefficients for
relationships between fτCFF and τCFF.
Moving–average time
window [s]
Bias Lower limit of
agreement
Upper limit of agreement rS
3 55.72 (40.05–71.40) −46.55 (−73.70
to−19.39)
158.00 (130.84–185.15) 0.63 p < .001
6 56.42 (39.88–72.97) −50.22 (−78.87
to−21.57)
163.07 (134.42–191.72) 0.58 p < .001
9 56.13 (38.45–71.80) −51.08 (−79.97
to−22.20)
161.34 (132.45–190.23) 0.54 p < .001
12 54.78 (38.10–71.45) −51.44 (−80.33
to−22.55)
161.00 (132.11–189.88) 0.59 p < .001
strongly correlated (see figure 5(A)). There was a substantial difference in bias between fτCFF and τCFF,
Bland–Altman analysis showing that on average fτCFF was 55.72 [ms] greater than τCFF (see figure 5(B)).
3.7.2. The PFF model.
A significant difference was found between fτPFF and τPFF (see table 3), and the effect size for this difference
was large: η2 = 0.46. There was a moderate but significant correlation between fτPFF and τPFF (see
figure 5(C)). The range between the lower and upper limits of agreement was wide. The mean ratio of fτPFF
to τPFF was 2.34, as shown in figure 5(D).
3.7.3. The CFF model vs. the PFF model.
Comparison of the CFF and PFF models showed that τCFF was significantly higher than τPFF, and that fτCFF
was significantly higher than fτPFF, see table 4. The effect size for the difference between τCFF and τPFF was
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Figure 4. Correlations and Bland–Altman plots for normalised compliance of the cerebral arterial bed assessed using non-invasive
and invasive ABP and the continuous flow forward model: fnCaCFF vs. nCaCFF (A) and (B), and the pulsatile flow forward model:
fnCaPFF vs. nCaPFF (C) and (D). Regression lines (solid lines) and 95% prediction intervals (dashed lines) are shown in (A) and
(C); rs—non-parametric Spearman’s rho correlation coefficients. The solid lines in (B) and (D) show bias (upper and lower limits
of agreement), whereas dashed lines show 95% confidence intervals for these limits; CI—confidence interval, SD—standard
deviation.
Table 4.Median values (lower quartile—upper quartile) of the time constant of the cerebral arterial bed, calculated using either the
continuous flow forward (CFF) model or the pulsatile flow forward (PFF) model and non-invasive ABP (fτCFF, fτPFF) or invasive ABP
(τCFF, τPFF).
Parameter
fτCFF [ms] τCFF [ms]
z; p–value
197.96 (151.08–238.15) 145.40 (104.52–182.63) z = 3.92; p < .001
fτPFF [ms] τPFF [ms]
93.30 (58.25–112.75) 43.48 (10.45–18.26) z = 4.33; p < .001
z; p-value z = 6.07; p < .001 z = 7.65; p < .001
z – non-parametric Mann–Whitney test statistic.
very large (η2 = 0.68), whereas that for the difference between fτCFF and fτPFF was smaller but still large
(η2 = 0.40).
4. Discussion
Our results demonstrated significant differences in τ calculated using fABP and ABP regardless of the model
used for estimation. Although a moderately strong, positive relationship was found between fτCFF and τCFF
(rs = 0.63), a Bland–Altman analysis showed a significant discrepancy between these two methods. Based on
limits of agreement, fτCFF was lower than τCFF by 47 ms (lower limit) and exceeded τCFF by 158 ms (upper
limit) for most measurements. The scatter around the observed bias was substantial, thus the agreement
between the two methods was rather poor. Correlational analysis indicated a moderate association between
fτPFF and τPFF (rs = 0.40). Moreover, Bland–Altman analysis showed that, on average, fτPFF was 2.34 times
greater than τPFF. When expressed as a mean ratio, there was a wide range between the upper and lower
limits of agreement for fτPFF and τPFF, illustrating weak agreement between the two methods.
The τ index represents the joint dependency of Ca and CVR (Czosnyka et al 2012). While fnCVR was
lower than nCVR, the size of this effect was trivial. On the other hand, fnCa was significantly higher than nCa
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Figure 5. Correlations and Bland–Altman plots for the time constant of the cerebral arterial bed assessed using non-invasive and
invasive ABP and the continuous flow forward model: fτCFF vs. τCFF (A) and (B), and the pulsatile flow forward model: fτPFF vs.
τPFF (C) and (D). Regression lines (solid lines) and 95% prediction intervals (dashed lines) are shown in (A) and (C);
rs—non-parametric Spearman’s rho correlation coefficients. The solid lines in (B) and (D) show bias (upper and lower limits of
agreement), whereas dashed lines show 95% confidence intervals for these limits; CI—confidence interval, SD—standard
deviation.
when calculated using either the CFF model or the PFF model. Similarly, fτ was significantly higher than τ
for both the CFF and PFF models.
Looking more deeply into the definition of nCa, this is estimated as the ratio between the pulse amplitude
of changes in normalized cerebral arterial blood volume and the amplitude of arterial blood pressure. When
the PFF model was applied, we found no significant difference between Amp(n∆CaBVPFF) estimated using
fABP and ABP. In the case of the CFF model, the ABP signal does not influence Amp(n∆CaBVCFF) as it is not
used in its calculation (see equation (3)). Thus, the differences in τ and fτ are mainly due to differences in
Amp(fABP) and Amp(ABP), regardless of the model used to estimate nCa and then τ. A coherence function
demonstrated good linear resemblance between ABP and fABP calculated in the frequency range
corresponding to pulse pressure changes with moderate attenuation of the pulse amplitudes of the fABP
signal. Bland–Altman analysis indicated that the average difference between Amp(fABP) and Amp(ABP) was
significant, the range between the limits of agreement was rather wide, and there was a moderate correlation
between the invasive and non-invasive methods of pressure pulse amplitude assessment. This latter
observation is in line with a previous study of (Panerai et al 2006) in which it was concluded that the first
harmonic of ABP measured by Finapres is smaller than that of ABP monitored invasively, and that this may
significantly influence estimation of the cerebral haemodynamic critical closing pressure parameter.
The accuracy of non-invasive ABP measurements using Finapres has been widely described for both
resting conditions and for different clinical scenarios using a variety of measurement conditions (Imholz et al
1991, 1998, Stokes et al 1991, Maestri et al 2005). The pressure gradient in the circulatory system along the
arterial tree results in lower mean pressure in fingers than in the radial artery (Bos et al 1995). Within
individuals, differences between non-invasive ABP measured from a finger and invasive ABP monitored in
the brachial or radial arteries have been reported to change from−13 [mm Hg] (fABP lower than ABP) to
25 [mmHg] (fABP higher than ABP; (Imholz et al 1998). In our study, the mean bias between the fABP and
ABP methods was−10.36 [mm Hg]. This discrepancy between non-invasive and invasive methods could
result from several interdependent factors: cuff size and application, the finger involved (middle or annular;
(Jones et al 1993), temperature of the hand (Hildebrandt et al 1991), or the finger’s level in relation to the
heart (Gizdulich et al 1995).
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This study is the first to examine how the calculation of window length used to average CBFV in the CFF
model influences the pulsatile amplitude of normalized changes in cerebral arterial blood volume. In
previous work, the minimum time for CBFV averaging was arbitrarily chosen to be equal to at least one full
period of a cardiac cycle (Kim et al 2009) or several previous heart evolutions (Czosnyka et al 2012). Our
results showed that a good choice for mean CBFV calculation is a 3 s window.
The study’s results confirmed our previous finding that τPFF is shorter than τCFF, regardless of whether
invasive or non-invasive ABP is used (Uryga et al 2019b). This is because the physiological interpretations of
these time–related cerebral blood flow indices differ. The τPFF index, which includes the influence of pulsatile
ABP characteristics, indexes filling of the arteries after a heart constriction, whereas the τCFF index, which
assumes a steady blood outflow, characterises the time in which blood reaches the arterioles (Uryga et al
2019a). Therefore, τPFF and τCFF should be used in a complementary manner to characterise the proximal
and distal parts of the cerebral arterial bed.
Despite the fact that there was poor agreement between the fτ and τmethods, the non-invasive approach
could be beneficial in patients suffering from hydrocephalus or stroke. Cerebrovascular disorders are a
common problem in chronic adult hydrocephalus patients, and these may cause further problems with shunt
placement (Boon et al 1999, Israelsson et al 2017). Severe cerebrovascular disease may lead to reduced
cerebral autoregulation, which impairs the ability to reperfuse the deep white matter after shunt placement
(Bateman 2000, Czosnyka et al 2002). Additionally, cerebrovascular disorders can cause a reduction in
cerebral blood flow, which can lead to a cerebral infarction, cerebral atrophy and a reduction in cerebrospinal
fluid outflow resistance. As a result, chronic hydrocephalus may be unresponsive to shunt implantation and
cause clinical symptoms similar to arteriosclerotic encephalopathy (Bateman 2004). Therefore, estimation of
fτ, which represents the relationship between compliance and resistance and is independent of a blood
vessel’s cross-sectional area, could be used to characterise cerebral haemodynamics in chronic adult
hydrocephalus patients during overnight ICP monitoring and infusion tests.
Invasive ABP monitoring might be impossible to perform in other neurocritical care patients because of
various contraindications such as local infections, coagulopathy, Raynaud syndrome, Buerger’s disease and
surgical considerations (Kaplan 2017). Invasive arterial blood pressure monitoring also carries some risks:
cannulation of an artery needs to be performed by a trained clinician, it is time-consuming, and can cause
the lesioning of nerves and vessels or even ischemia, although this rarely happens (Scheer et al 2002). Hence,
the estimation of τ using non-invasive ABP could be used to assess the mechano-elastic properties of the
cerebrovascular bed in patients for whom invasive ABP measurement is impossible or in whom it is likely to
have adverse consequences.
5. Limitations
Although 46 independent signal recordings were analysed, only a small number of TBI patients (10) were
included in the study. Also, certain factors which were not considered may have influenced our findings:
patients’ BMIs and their general health, the severity of brain injuries and their outcomes, treatments given,
and other clinical circumstances (body position, temperature, sedation and analgesia, drugs administered,
use of mechanical respiration, respiratory strategy used, etc). Thus, further research needs to be performed
using a larger, homogenous cohort of TBI subjects to examine whether there is any correlation between τ
and patients’ clinical states. This said, several studies of τ in TBI patients have been published previously. The
results of research on 161 TBI patients (Trofimov et al 2016) suggested that autoregulation of cerebral
capillary blood flow fails in patients with severe TBI and that the total volume of capacitive vessels is reduced
as an effect of brain oedema, which results in a significantly shorter τ in such patients compared to normal
subjects. Another study showed that hypocapnia performed in 27 TBI patients caused a prolongation of τ as
a result of increased cerebrovascular resistance which was greater than the decrease in compliance of the
cerebral arterial bed (Puppo et al 2019). Also, Sheludyakov et al (2020) found that τ for 43 TBI patients who
had ipsilateral haematoma and cerebral vasospasm was shorter than for 41 TBI patients without haematoma.
All these previous findings suggest the potential utility of τ in describing cerebral haemodynamics in TBI
patients.
The presently analysed data were digitally recorded almost 30 years ago. However, since then little, has
changed in ICP, invasive blood pressure, TCD and Finapres monitoring. The signals analysed were
technically sound, signal to noise ratios were within the limits of contemporary recordings, and sampling
frequencies were satisfactory. We therefore used retrospective data to minimize the burden of performing
new monitoring in a busy NCCU environment.
An updated version of the Finapres 2300 (the Finometer Midi) and the latest non-invasive continuous
blood pressure monitor (the Finapres NOVA) provide a significant improvement in measurement accuracy
by using several methods to correct for physiological radial or brachial to finger differences, including
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waveform filtering, level correction, and continuous calibration (Guelen et al 2003). Further studies are
needed to investigate agreement between cerebral haemodynamic indices estimated measuring ABP
invasively and non-invasively by using this latest generation of non-invasive continuous blood pressure
devices.
6. Conclusions
Differences between fτ and τ are significant. For head injury patients, estimation of τ using non-invasive
ABP monitoring is inaccurate when using both the CFF and PFF modelling approaches.
Acknowledgments
The authors wish to thank all members of the Neurosciences Critical Care Unit of Addenbrooke’s Hospital,
Cambridge, UK for participating in data monitoring. The currently analysed signals were previously used in
analyses of cerebral pressure autoregulation in the low frequency range (Lavinio et al 2007) and
cerebrovascular pressure reactivity in the low frequency range (Kasprowicz et al 2010). The authors
acknowledge the support of the Polish National Agency for Academic Exchange under the International
Academic Partnerships programme. A. Uryga is supported by the Foundation for Polish Science (FNP).
Disclosure
The ICM+ software (www.neurosurg.cam.acuk/icmplus) is licensed by the University of Cambridge,
Cambridge, UK, and Professor M. Czosnyka has a financial interest in part of the licensing fee.
References
Bateman G A 2000 Vascular compliance in normal pressure hydrocephalus Am. J. Neuroradiol. 21 11039334
Bateman G A 2004 Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer’s disease, vascular dementia and normal
pressure hydrocephalusMed. Hypotheses 62 182–7
Bland J M and Altman D G 1986 Statistical methods for assessing agreement between two methods of clinical measurement Lancet
1 307–10
Bland J M and Altman D G 1999 Measuring agreement in method comparison studies Stat. Methods Med. Res. 8 135–60
Boon A J W, Tans J T J, Delwel E J, Egeler-Peerdeman S M, Patrick W H, Wurzer H A L and Hermans J 1999 Dutch normal-pressure
hydrocephalus study: the role of cerebrovascular disease J. Neurosurg. 90 221–6
Bos W J W, Van Den Meiracker A H, Wesseling K H and Schalekamp M A D H 1995 Effect of regional and systemic changes in
vasomotor tone on finger pressure amplification Hypertension 26 315–20
Calviello L A, Zeiler F A, Donnelly J, Uryga A, de Riva N, Smielewski P and Czosnyka M 2019 Estimation of pulsatile cerebral arterial
blood volume based on transcranial doppler signalsMed. Eng. Phys. 74 23–32
Capel C, Kasprowicz M, Czosnyka M, Baledent O, Smielewski P, Pickard J D and Czosnyka Z 2014 Cerebrovascular time constant in
patients suffering from hydrocephalus Neurol. Res. 36 255–61
Carrera E, Kim D J, Castellani G, Zweifel C, Smielewski P, Pickard J D and Czosnyka M 2011 Effect of hyper- and hypocapnia on cerebral
arterial compliance in normal subjects J. Neuroimaging 21 121–5
Chatterjee A, Depriest K, Blair R, Bowton D and Chin R 2010 Results of a survey of blood pressure monitoring by intensivists in
critically ill patients: a preliminary study Crit. Care Med. 38 2335–8
Czosnyka M, Piechnik S, Richards H K, Kirkpatrick P, Smielewski P and Pickard J D 1997 Contribution of mathematical modelling to
the interpretation of bedside tests of cerebrovascular autoregulation J. Neurol. Neurosurg. Psychiatry 63 721–31
Czosnyka M, Richards H, Pickard J D, Harris N and Iyer V 1994 Frequency-dependent properties of cerebral blood transport-an
experimental study in anaesthetized rabbits Ultrasound Med. Biol. 20 391–9
Czosnyka M, Richards H K, Reinhard M, Steiner L A, Budohoski K, Smielewski P, Pickard J D and Kasprowicz M 2012 Cerebrovascular
time constant: dependence on cerebral perfusion pressure and end-tidal carbon dioxide concentration Neurol. Res. 34 17–24
Czosnyka Z, Czosnyka M, Pickard J D and Chari A 2016 Who needs a revision? 20 years of Cambridge shunt lab Acta Neurochir. Suppl.
122 347–51
Czosnyka Z H, Czosnyka M, Whitfield P C, Donovan T, Pickard J D, Milhorat T H, Selman W R, Gjerris F and Juhler M 2002 Cerebral
autoregulation among patients with symptoms of hydrocephalus Neurosurgery 50 526–3
Fritz C O, Morris P E and Richler J J 2012 Effect size estimates: current use, calculations, and interpretation J. Exp. Psychol. Gen. 141 2–18
Gizdulich P, Aschero G, Guerrisi M and Wesseling K 1995 Effect of hydrostatic pressure of finger pressure measured with Finapres
Homeostasis 36 120–9
Guelen I, Westerhof B E, Van Der Sar G L, Van Montfrans G A, Kiemeneij F, Wesseling K H and Bos W J W 2003 Finometer, finger
pressure measurements with the possibility to reconstruct brachial pressure Blood Press. Monit. 8 27–30
Hildebrandt W, Schütze H and Stegemann J 1991 On the reliability of the Penaz cuff during systemic and local fingertip vasodilatation
at rest and in exercise Eur. J. Appl. Physiol. Occup. Physiol. 62 175–9
Imholz B P M, Wieling W, Langewouters G J and van Montfrans G A 1991 Continuous finger arterial pressure: utility in the
cardiovascular laboratory Clin. Auton. Res. 1 43–53
Imholz B P M, Wieling W, Van Montfrans G A and Wesseling K H 1998 Fifteen years experience with finger arterial pressure
monitoring: assessment of the technology Cardiovasc. Res. 38 605–16
Israelsson H, Carlberg B, Wikkelsö C, Laurell K, Kahlon B, Leijon G, Eklund A and Malm J 2017 Vascular risk factors in INPH: a
prospective case-control study (the INPH-CRasH study) Neurology 88 577–85
12
Physiol. Meas. 41 (2020) 075001 A Uryga et al
Jones R D M, Kornberg J P, Roulson C J, Visram A R and Irwin M G 1993 The Finapres 2300e finger cuff: the influence of cuff
application on the accuracy of blood pressure measurement Anaesthesia 48 611–5
Kaplan J A 2017 Kaplan’s Essentials of Cardiac Anesthesia for Cardiac Surgery (Amsterdam: Elsevier) (https://www.elsevier.com/
books/kaplans-essentials-of-cardiac-anesthesia/9780323497985)
Kasprowicz M, Czosnyka M, Soehle M, Smielewski P, Kirkpatrick P J, Pickard J D and Budohoski K P 2012a Vasospasm shortens
cerebral arterial time constant Neurocrit. Care 16 213–8
Kasprowicz M et al 2012b Time constant of the cerebral arterial bed Acta Neurochir. Suppl. 114 17–21
Kasprowicz M, Diedler J, Reinhard M, Carrera E, Steiner L A, Smielewski P, Budohoski K P, Haubrich C, Pickard J D and Czosnyka M
2012c Time constant of the cerebral arterial bed in normal subjects Ultrasound Med. Biol. 38 1129–37
Kasprowicz M, Schmidt E, Kim D J, Haubrich C, Czosnyka Z, Smielewski P and Czosnyka M 2010 Evaluation of the cerebrovascular
pressure reactivity index using non-invasive Finapres arterial blood pressure Physiol. Meas. 31 1217–28
Kim D-J, Kasprowicz M, Carrera E, Castellani G, Zweifel C, Lavinio A, Smielewski P, Sutcliffe M P F, Pickard J D and Czosnyka M 2009
The monitoring of relative changes in compartmental compliances of brain Physiol. Meas. 30 647–59
Lavinio A, Schmidt E A, Haubrich C, Smielewski P, Pickard J D and Czosnyka M 2007 Noninvasive evaluation of dynamic
cerebrovascular autoregulation using finapres plethysmograph and transcranial Doppler Stroke 38 402–4
Liew B, Takagi K, Kato Y, Duvuru S, Thanapal S and Mangaleswaran B 2019 Current updates on idiopathic normal pressure
hydrocephalus Asian J. Neurosurg. 14 648–56
Maestri R, Pinna G D, Robbi E, Capomolla S and La Rovere M T 2005 Noninvasive measurement of blood pressure variability: accuracy
of the Finometer monitor and comparison with the Finapres device Physiol. Meas. 26 1125–36
Menon D K 1999 Cerebral protection in severe brain injury: physiological determinants of outcome and their optimisation Br. Med.
Bull. 55 226–58
Panerai R B, Sammons E L, Smith S M, Rathbone W E, Bentley S, Potter J F, Evans D H and Samani N J 2006 Cerebral critical closing
pressure estimation from Finapres and arterial blood pressure measurements in the aorta Physiol. Meas. 27 1387
Petersen N H, Ortega-Gutierrez S, Reccius A, Masurkar A, Huang A and Marshall R S 2014 Comparison of non-invasive and invasive
arterial blood pressure measurement for assessment of dynamic cerebral autoregulation Neurocrit. Care 20 60–68
Puppo C, Kasprowicz M, Steiner L A, Yelicich B, Lalou D A, Smielewski P and Czosnyka M 2019 Hypocapnia after traumatic brain
injury: how does it affect the time constant of the cerebral circulation? J. Clin. Monit. Comput. 34 461–8
Ragland J and Lee K 2016 Critical care management and monitoring of intracranial pressure J. Neurocrit. Care 9 105–12
Scheer B V, Perel A and Pfeiffer U J 2002 Clinical review: complications and risk factors of peripheral arterial catheters used for
haemodynamic monitoring in anaesthesia and intensive care medicine Crit. Care 6 199–204
Sheludyakov A, Martynov D, Yuryev M, Kopylov A and Trofimov A 2020 The cerebrovascular time constant in patients with head injury
and posttraumatic cerebral vasospasm Acta Neurochir. Suppl. 127 191–4
Silke B, Spiers J P, Boyd S, Graham E, Mcparland G and Scott M E 1994 Evaluation of non-invasive blood pressure measurement by the
Finapres method at rest and during dynamic exercise in subjects with cardiovascular insufficiency Clin. Auton. Res. 4 49–56
Stokes D N, Clutton-brock T, Patil C, Thompson J M and Hutton P 1991 Comparison of invasive and non-invasive measurement of
continuous arterial pressure using the finapres Br. J. Anaesth. 67 26–35
Trofimov A, Kalentiev G, Gribkov A, Voennov O and Grigoryeva V 2016 Cerebrovascular time constant in patients with head injury.
Acta Neurochir. Suppl. 121 295–7
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